USPTO serial 97383925
ADV
Reviewed by CopyMark Law Group
Status 601
- Filing date
- Status date
- Registration date
- —
- Examiner
- CLONCH, ABIGAIL
- Law office
- LAW OFFICE 117 - EXAMINING ATTORNEY ASSIGNED
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ADV?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Meghna Prasad
Meghna Prasad BAKER BOTTS L.L.P.44TH FLOOR30 ROCKEFELLER PLAZANEW YORK, NY 10112-4498Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | A full line of pharmaceuticals for the treatment of depression, hypertension, malaria, metastatic prostate cancer, benign prostatic hyperplasia, partial seizures in adults with epilepsy, attention deficit hyperactivity disorder (ADHD), heart failure in adults, heart failure in pediatric patients, atrial fibrillation in adults, edema associated with congestive heart failure, edema associated with cirrhosis of the liver, edema associated with nephrotic syndrome, steroid-induced edema, idiopathic edema, edema due to secondary hyperaldosteronism, acute enterocolitis, duodenal ulcer, and irritable bowel syndrome being irritable colon, spastic colon, mucous colitis; anti-inflammatory medicines, and immunosuppressive agents, namely, corticosteroids; pharmaceutical preparations for the treatment of cancers and abnormal cells; all of the foregoing excluding pharmaceutical preparations acting on the peripheral or central nervous system, surgical kits comprised of medical and surgical apparatus and instruments, and surgical implants comprised of human and animal tissue; all of the foregoing excluding anti-infective pharmaceutical preparations | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 2, 2023 | MAB1 | ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT | — |
| May 2, 2023 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| May 1, 2023 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Apr 27, 2023 | LOPR | LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN | — |
| Mar 24, 2023 | LOPT | LETTER OF PROTEST EVIDENCE FORWARDED | — |
| Feb 2, 2023 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jan 24, 2023 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jan 24, 2023 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jan 24, 2023 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 24, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 24, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 24, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 24, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 18, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| May 3, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 30, 2022 | NWAP | NEW APPLICATION ENTERED | — |